Emerging drugs for the treatment of symptoms associated with autism spectrum disorders

Brain Serotonin and Dopamine Transporter Bindings in Adults With High-Functioning Autism

(2010) Kazuhiko Nakamura et al.   ARCHIVES OF GENERAL PSYCHIATRY

MONOAMINES (SEROTONIN AND CATECHOLAMINES) AND THEIR DERIVATIVES IN INFANTILE AUTISM: AGE-RELATED CHANGES AND DRUG EFFECTS

(2010) Jöelle Martineau et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

The Peptide That Binds

(2010) Kai MacDonald et al.   HARVARD REVIEW OF PSYCHIATRY

Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior

(2009) Bryan H. King et al.   ARCHIVES OF GENERAL PSYCHIATRY

Genetic advances in autism: heterogeneity and convergence on shared pathways

(2009) Brent R Bill et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Autism: an emerging ‘neuroimmune disorder’ in search of therapy

(2009) Theoharis C Theoharides et al.   EXPERT OPINION ON PHARMACOTHERAPY

A Placebo-Controlled, Fixed-Dose Study of Aripiprazole in Children and Adolescents With Irritability Associated With Autistic Disorder

(2009) Ronald N. Marcus et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder

(2009) R. Owen et al.   PEDIATRICS

Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism

(2009) Shahin Akhondzadeh et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Antipsychotics in the treatment of autism

(2008) David J. Posey et al.   JOURNAL OF CLINICAL INVESTIGATION

Guanfacine in Children with Autism and/or Intellectual Disabilities

(2008) Benjamin L. Handen et al.   JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS